𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Two-year biochemical, virological, and histological follow-up in patients with chronic hepatitis C responding in a sustained fashion to interferon alfa-2b treatment

✍ Scribed by Olle Reichard; Hans Glaumann; Aril Frydén; Gunnar Norkrans; Robert Schvarcz; Anders Sönnerborg; Zhi-Bing Yun; Ola Weiland


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
551 KB
Volume
21
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

✦ Synopsis


OLLE REICHARD,l HANS GLAUMA",2'3 h I L FRYDEN? GUNNAR NORKRANS,' ROBERT SCHvARCZ,2 ANDERS SONNERBORG,2'6 ZHI-BING YUN,' AND OLA WEILAND2

Fourteen patients with chronic hepatitis C who had a sustained response to a 60-week interferon alfa-2b treatment course were followed, biochemically and virologically, 2 years after treatment cessation. Biopsies were repeated in 12 of 14 for histological and virological evaluation at 2-year follow-up. AU 14 patients had normal serum alanine transaminase (SALT) levels and were negative for hepatitis C virus (HCV) RNA in serum during treatment and at short-term follow-up 6 months posttreatment. At 2-year follow-up, 13 patients still had normal ALT levels (<0.6 pkatn for women; <0.8 pkatn for men), 1 a near normal level (0.76 pkatn); all were HCV RNA negative in serum, and 11 of 12 also in the liver. Liver histology improved during treatment and remained stable during the 2-year follow-up. The authors conclude that most sustained responders, who have normal ALT levels and are nonviremic at short-term followup 6 months after interferon treatment, will continue to have a durable long-term response without relapse of the viremia (HEPATOLOGY 1995;21:918-922.) Approximately 15% to 35% of alfa-interferontreated patients with chronic hepatitis C virus (HCV) infection will have a long-term response.'-4 The definition of treatment response has, however, varied. Most authors have used normalization of serum alanine transaminase (SALT) levels alone as a marker of response, whereas we and others have included also the eradication of HCV RNA from Because HCV RNA often is detected in serum of patients with normal Abbreviations: HCV, hepatitis C virus; SALT, serum alanine transaminase.


📜 SIMILAR VOLUMES


Biochemical and virological outcome of p
✍ E K Manesis; C Papaioannou; A Gioustozi; G Kafiri; J Koskinas; S J Hadziyannis 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB 👁 2 views

To compare two interferon (IFN) schedules for the treatment of chronic hepatitis C, we followed 211 patients who received 3 million units IFN-alpha2b thrice weekly for either 6 months (group 1; 85 patients) or 12 months (group 2; 126 patients), with a median follow-up of 3.4 (0.1-8.4) and 4.2 (0.7-8

Combined treatment with interferon alpha
✍ R. Schvarcz; Z. B. Yun; A. Sönnerborg; O. Weiland 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 442 KB 👁 2 views

Ten patients with chronic hepatitis C, six of whom had not responded and four of whom had responded in a non-sustained fashion to interferon-alpha treatment alone, were given interferon alpha-2b and ribavirin in combination during 24 weeks. Interferon alpha-2b was given subcutaneously, at a dose of